Nicol Bernardinello
Overview
Explore the profile of Nicol Bernardinello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernardinello N, Zen M, Castelli G, Cocconcelli E, Balestro E, Borie R, et al.
Front Med (Lausanne)
. 2025 Mar;
12:1542400.
PMID: 40066169
Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects millions of people worldwide and is characterized by persistent inflammation, pain, and joint destruction. In RA, the dysregulation of the...
2.
Cocconcelli E, Bernardinello N, Cameli P, Di Liberti R, Alhamad E, Gregori D, et al.
Lung
. 2025 Feb;
203(1):35.
PMID: 39998625
Purpose: The natural history of IPF remains unpredictable despite antifibrotic treatment. In addition, some patients discontinue treatment due to the occurrence of adverse events. To date, no data exist on...
3.
Fiorentu G, Bernardinello N, Giulianelli G, Cocconcelli E, Balestro E, Spagnolo P
Adv Ther
. 2025 Feb;
PMID: 39969780
Pulmonary hypertension (PH) is a progressive syndrome characterized by increased pulmonary artery pressure. PH often complicates chronic lung diseases, thus contributing to a substantial disease burden and poor prognosis. The...
4.
Tana C, Bernardinello N, Raffaelli B, Garcia-Azorin D, Waliszewska-Prosol M, Tana M, et al.
Ann Med
. 2024 Dec;
57(1):2445191.
PMID: 39723989
Background: There has been significant progress in understanding neurosarcoidosis (NS) as a distinct disorder, which encompasses a heterogeneous group of clinical and radiological alterations which can affect patients with systemic...
5.
Cocconcelli E, Balestro E, Turato G, Fiorentu G, Bazzan E, Biondini D, et al.
Front Immunol
. 2024 Oct;
15:1437767.
PMID: 39464888
Background: Recent literature has shown the presence of B cells and autoantibodies in idiopathic pulmonary fibrosis (IPF) which would imply the presence of tertiary lymphoid structures (TLS, sites where the...
6.
Bernardinello N, Castelli G, Pasin D, Grisostomi G, Cola M, Giraudo C, et al.
Diagnostics (Basel)
. 2024 Oct;
14(20).
PMID: 39451643
Background: Even after the development of vaccines, SARS-CoV-2 continues to cause severe pneumonia all over the world. Consequently, in order to improve the management of patients and optimize the use...
7.
Ramalhosa F, Lunardi F, Bernardinello N, Gori S, Pezzuto F, Tauro V, et al.
Arch Pathol Lab Med
. 2024 Oct;
PMID: 39396825
Context.—: Coronavirus disease 2019 (COVID) primarily affects the lung and can lead to chronic/post-COVID syndrome. Some insights about late pulmonary changes occurring in patients recovering from COVID have been published,...
8.
Casara A, Conti M, Bernardinello N, Tine M, Baraldo S, Turato G, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000595
Depending on local cues, macrophages can polarize into classically activated (M1) or alternatively activated (M2) phenotypes. This study investigates the impact of polarized macrophage-derived Extracellular Vesicles (EVs) (M1 and M2)...
9.
Tine M, Balestro E, Carpi S, Neri T, Biondini D, Conti M, et al.
Front Immunol
. 2024 Mar;
15:1320077.
PMID: 38533493
Background: The family of Suppressor of Cytokine Signaling (SOCS) acts as a controller of the duration and intensity of cytokine function by negatively regulating the JAK-STAT signaling pathway. SOCS' role...
10.
Israel-Biet D, Bernardinello N, Pastre J, Tana C, Spagnolo P
Diagnostics (Basel)
. 2024 Feb;
14(4).
PMID: 38396434
Although sarcoidosis is generally regarded as a benign condition, approximately 20-30% of patients will develop a chronic and progressive disease. Advanced pulmonary fibrotic sarcoidosis and cardiac involvement are the main...